City State Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Hold
856
0.03% 256
2026
Q1
$131K Hold
856
0.03% 240
2025
Q4
$118K Buy
856
+1
+0.1% +$131 0.03% 257
2025
Q3
$110K Hold
855
0.03% 265
2025
Q2
$103K Hold
855
0.03% 263
2025
Q1
$95.3K Hold
855
0.03% 267
2024
Q4
$83.2K Hold
855
0.03% 272
2024
Q3
$98.3K Hold
855
0.04% 263
2024
Q2
$91K Hold
855
0.04% 254
2024
Q1
$83K Hold
855
0.04% 262
2023
Q4
$86K Hold
855
0.04% 249
2023
Q3
$87K Hold
855
0.05% 237
2023
Q2
$86K Hold
855
0.05% 244
2023
Q1
$79K Hold
855
0.05% 244
2022
Q4
$78K Hold
855
0.05% 233
2022
Q3
$65K Hold
855
0.05% 236
2022
Q2
$72K Sell
855
-35
-4% -$3.07K 0.05% 229
2022
Q1
$78K Hold
890
0.05% 236
2021
Q4
$78K Buy
+890
New +$73.9K 0.05% 246

Other funds holding NVS

City State Bank's NVS Position: Q2 2026 in Review

City State Bank held its Novartis (NVS) position steady in Q2 2026 at 856 shares worth $134K. The position accounts for 0.03% of the portfolio, ranked #256.

City State Bank first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. 734 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • City State Bank held 856 shares of Novartis worth $134K as of Q2 2026.
  • City State Bank left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.03% of City State Bank's portfolio in Q2 2026, its #256 holding.
  • City State Bank first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
  • 734 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.